GLP-1 receptor agonists may be considered when additional treatment goals include weight reduction, improved glycemic control, chronic kidney disease risk reduction, or lowering atherosclerotic cardiovascular risk, particularly in patients with obesity or established Atherosclerotic Cardiovascular Disease (ASCVD) [7, 16, 47]
Glutathion rt d b phn ng oxy ha trong nc
An ton di hn : Cha r , v c rt t nghin cu trn ngi tn ti
Many herbal supplements, including Moringa, have properties that can affect blood sugar levels, similar to Ozempic
3.3 Risk of bias in studies Figures 2, 3 present the risk of bias assessment results